Remediation Response to FDA 483 Observations Case Study

This case study outlines the remediation response process undertaken by ProPharma for a small contract manufacturer that received an FDA 483 Observation notice. The document details the initial intake and collaboration between the client, ProPharma, and an external legal firm to develop a comprehensive response plan within a tight timeframe. Over a period of sixteen weeks, ProPharma coordinated efforts to address system-wide concerns identified in the Form 483, including incomplete validations and inadequate document control processes. The remediation plan involved engaging skilled leaders in Quality Management Systems and Validation, managing resource loading, and implementing a phased approach to bring production lines back online. The case study highlights the use of Six Sigma DMAIC methodology in the remediation efforts and emphasizes the importance of collaboration and transparency throughout the process. Ultimately, the site received an Establishment Inspection Report from the FDA and completed the necessary action plan, demonstrating ProPharma's scalable approach to compliance and remediation.